Stockscreener 앱 받기
0.3681
6.55%
-0.0259
전일 마감가:
$0.394
열려 있는:
$0.3921
하루 거래량:
861.69K
Relative Volume:
0.10
시가총액:
$8.03M
수익:
-
순이익/손실:
$-6.07M
주가수익비율:
-0.0637
EPS:
-5.78
순현금흐름:
$-7.34M
1주 성능:
-1.63%
1개월 성능:
-18.40%
6개월 성능:
-53.40%
1년 성능:
-62.23%
1일 변동 폭
$0.3661
$0.4049
1주일 범위
$0.3661
$0.4156
52주 변동 폭
$0.22
$1.30
Adial Pharmaceuticals Inc Stock (ADIL) Company Profile
명칭
Adial Pharmaceuticals Inc
전화
434-422-9800
주소
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
ADIL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADIL
Adial Pharmaceuticals Inc
|
0.3681 | 8.52M | 0 | -6.07M | -7.34M | -5.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.24 | 100.71B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.97 | 61.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.23 | 58.84B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
663.72 | 40.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.69 | 38.20B | 3.81B | -644.79M | -669.77M | -6.24 |
Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-14 | 개시 | Rodman & Renshaw | Buy |
| 2018-10-30 | 개시 | Maxim Group | Buy |
| 2018-10-11 | 개시 | Dawson James | Buy |
Adial Pharmaceuticals Inc 주식(ADIL)의 최신 뉴스
Is Adial Pharmaceuticals Inc. stock a good dividend stockJuly 2025 Trade Ideas & Community Trade Idea Sharing - thegnnews.com
What moving averages say about Adial Pharmaceuticals Inc.July 2025 Catalysts & Free High Accuracy Swing Entry Alerts - Newser
Analyzing Adial Pharmaceuticals Inc. with multi timeframe chartsEarnings Miss & Advanced Technical Signal Analysis - Newser
Is Adial Pharmaceuticals Inc. stock entering bullish territoryJobs Report & Momentum Based Trading Signals - Newser
Backtesting results for Adial Pharmaceuticals Inc. trading strategiesBear Alert & Risk Adjusted Buy/Sell Alerts - Newser
Multi asset correlation models including Adial Pharmaceuticals Inc.July 2025 Levels & Low Risk High Reward Trade Ideas - Newser
Adial Pharmaceuticals Receives Hold Rating from Maxim Group - AInvest
Key metrics from Adial Pharmaceuticals Inc.’s quarterly data2025 Stock Rankings & Daily Entry Point Trade Alerts - Newser
Can Adial Pharmaceuticals Inc. Bounce Back From Weekly Low2025 Performance Recap & Weekly Chart Analysis and Trade Guides - sundaytimes.kr
Short Interest in Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Expands By 919.9% - Defense World
Exit strategy if you’re trapped in Adial Pharmaceuticals Inc.Market Trend Summary & Reliable Momentum Entry Alerts - Newser
Adial Pharmaceuticals Q2 Earnings: Net Loss Down to $2M - AInvest
Adial Pharmaceuticals expects cash to fund operations into Q2 of 2026 - TipRanks
Adial Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update - TradingView
Adial's Genetic-Targeted Alcohol Treatment Heads to Phase 3 After FDA Green Light - Stock Titan
Will Adial Pharmaceuticals Inc. Stock Benefit from AI and Green Energy TrendsMarket Activity Report & Low Risk Entry Point Guides - Newser
Adial Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Adial Pharmaceuticals files to register resale of 6.7M shares from warrant conversions - MSN
Will Adial Pharmaceuticals Inc. outperform the marketFree Community Shared Smart Money Signals - Newser
Why Adial Pharmaceuticals Inc. stock attracts strong analyst attentionStock Holding Strategy Long-Term Summary Sheet - Newser
ADIL financial health comparison - AInvest
Price momentum metrics for Adial Pharmaceuticals Inc. explainedFree Weekly Chart Analysis With Entry Advice - Newser
Adial Pharmaceuticals (ADIL) to Release Quarterly Earnings on Tuesday - Defense World
Adial Pharmaceuticals Inc expected to post a loss of 25 cents a shareEarnings Preview - TradingView
Adial Pharmaceuticals Completes FDA Meeting, Advances AD04 into Phase 3 Clinical Development - AInvest
Adial Pharmaceuticals' Regulatory and Strategic Momentum with AD04: A Catalyst for Partnership and Growth in a High-Potential Market - AInvest
Adial Pharmaceuticals completes FDA meeting for alcohol disorder drug By Investing.com - Investing.com South Africa
Adial Pharmaceuticals Completes Successful EOP2 FDA Meeting | AD - GuruFocus
Adial Pharmaceuticals completes FDA meeting for alcohol disorder drug - Investing.com
Adial Pharmaceuticals Completes Successful EOP2 FDA Meeting - GlobeNewswire
Adial Pharmaceuticals Completes Successful FDA Meeting for Phase 3 Trial of AD04 for Alcohol Use Disorder Treatment. - AInvest
Adial's Alcohol Addiction Treatment Gets FDA Green Light for Pivotal Phase 3 Trial, Partnership Talks Heat Up - Stock Titan
Candlestick Reversal Detected on Adial Pharmaceuticals Inc.’s ChartProfit Focused Trade Alerts - beatles.ru
Sentiment Tools Show Shift in Trader Mood on Adial Pharmaceuticals Inc.Weekly Stock Opportunity Radar Scanner Activated - beatles.ru
Technical Bounce Expected in Adial Pharmaceuticals Inc. Next WeekSector Based Breakout Stock Forecast Issued - metal.it
Published on: 2025-08-04 18:30:20 - beatles.ru
Why CommScope Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket - Benzinga
What is the risk reward ratio of investing in Adial Pharmaceuticals Inc. stockBuild wealth with reliable stock picks - Jammu Links News
How many analysts rate Adial Pharmaceuticals Inc. as a “Buy”Rapid growth opportunities - Jammu Links News
What drives Adial Pharmaceuticals Inc. stock priceTriple returns potential - Jammu Links News
How does Adial Pharmaceuticals Inc. generate profit in a changing economyBoost your returns with professional guidance - Jammu Links News
What analysts say about Adial Pharmaceuticals Inc. stockHigh-profit capital plays - Jammu Links News
How strong is Adial Pharmaceuticals Inc. company’s balance sheetFree Stock Selection - Jammu Links News
Adial Pharmaceuticals Approves Share Increase Amid Ongoing Financial Struggles - AInvest
What is Adial Pharmaceuticals Inc. company’s growth strategyGet timely alerts on market opportunities - Jammu Links News
What is the dividend policy of Adial Pharmaceuticals Inc. stockGet exclusive market analysis for investors - Jammu Links News
What are Adial Pharmaceuticals Inc. company’s key revenue driversMaximize returns with disciplined trading approaches - Jammu Links News
What catalysts could drive Adial Pharmaceuticals Inc. stock higher in 2025Dynamic growth stocks - Jammu Links News
Published on: 2025-08-03 01:06:20 - jammulinksnews.com
Healthcare Stocks Move in Friday's After-Market Session: Psyence Biomedical Tops Gainers List - AInvest
Is Adial Pharmaceuticals Inc. a growth stock or a value stockBreakout Stocks Tracker With High Returns - jammulinksnews.com
Adial Pharmaceuticals Inc (ADIL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.30%
자본화:
|
볼륨(24시간):